GCM
TECH icon

Glenview Capital Management’s Bio-Techne TECH Stock Holding History

Glenview Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.12M Sell
58,324
-127,988
-69% -$6.91M 0.08% 45
2026
Q1 		$9.74M Sell
186,312
-433,632
-70% -$26M 0.24% 43
2025
Q4 		$36.5M Buy
619,944
+245,893
+66% +$14.9M 0.74% 36
2025
Q3 		$20.8M Buy
+374,051
New +$20M 0.46% 39

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Glenview Capital Management's TECH Position: Q2 2026 in Review

Glenview Capital Management reduced its Bio-Techne (TECH) stake by 69% in Q2 2026, selling an estimated $6.91M and leaving 58,324 shares worth $4.12M. The position accounts for 0.08% of the portfolio, ranked #45.

Glenview Capital Management first reported a position in TECH in Q3 2025 and has held it in 4 quarters since. The position peaked at $36.5M in Q4 2025. 595 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Glenview Capital Management held 58,324 shares of Bio-Techne worth $4.12M as of Q2 2026.
  • Glenview Capital Management sold 127,988 Bio-Techne shares in Q2 2026, an estimated $6.91M.
  • Bio-Techne made up 0.08% of Glenview Capital Management's portfolio in Q2 2026, its #45 holding.
  • Glenview Capital Management first reported a position in Bio-Techne in Q3 2025 and has held it in 4 quarters since.
  • Glenview Capital Management's Bio-Techne position peaked at $36.5M in Q4 2025.
  • 595 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Glenview Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.